Late-gestational intrauterine hypoxia represents a well-known risk factor of acquired perinatal brain injury. Cell type and age-specific sensitivity of hypoxia-responsive genes to low-oxygen partial pressure is to be considered in the screening for early indicators of fetoplacental tissue hypoxia. To identify early hypoxia-induced alterations in gene expression during late-gestational hypoxia (6% O 2, 6 h; gestational day 20) we compared primary mouse placenta and brain transcriptomes using highdensity oligonucleotide microarrays. Upregulation of candidate marker genes for hypoxia was confirmed by quantitative RT-PCR and immunohistochemistry. Both developing brain and placenta were highly responsive to systemic hypoxia at the level of gene expression involving hypoxia-inducible transcription factor (HIF)-dependent genes and immediate early genes (IEG) (Fos, Jun, Egr1, Bhlhb2), apoptosis-promoting factors (Bnip3, Dusp1, Ier3) that were all upregulated, and genes modulating RNA binding and translation (Rbm3, Thap2, Lig4, Rbm12b) that mainly were downregulated. Functional activity of the HIF system was obvious from elevated expression of various known HIF target genes (Adm, Vegf, Hk2, Pdk1, Bnip3, Ier3, Dusp-1), indicating immediate availability among early response to acute hypoxia. In addition, genes not yet described as being hypoxia related were identified that are involved in angiogenesis/cell differentiation (Gna13, Gab2), mRNA processing, and embryonic development. RT-PCR of placenta and brain tissues confirmed upregulation of selected HIF target genes and IEG. These data indicate that the early hypoxia-induced genomic response of the placenta mirrors that of developing brain in a temporally parallel manner. Our observations implicate future diagnostic options to identify fetal and cerebral tissue hypoxia. fetal hypoxia; hypoxia-inducible transcription factors; immediate early genes; apoptosis FETAL AND LATE-GESTATIONAL intrauterine hypoxia lead to tremendous consequences for neurodevelopmental long-term development of the newborn. Uteroplacental as well as placental insufficiency are well-known risk factors of diminished oxygen and energy supply of the fetus (28, 45). Clinical and scientific interest on early identification of neonates at risk of hypoxic brain injury is evident from several studies on brain-specific biochemical markers intending to diagnose subclinical stages of hypoxic brain injury and to predict severity of hypoxicischemic encephalopathy (11, 14, 47, 48) .
FETAL AND LATE-GESTATIONAL intrauterine hypoxia lead to tremendous consequences for neurodevelopmental long-term development of the newborn. Uteroplacental as well as placental insufficiency are well-known risk factors of diminished oxygen and energy supply of the fetus (28, 45) . Clinical and scientific interest on early identification of neonates at risk of hypoxic brain injury is evident from several studies on brain-specific biochemical markers intending to diagnose subclinical stages of hypoxic brain injury and to predict severity of hypoxicischemic encephalopathy (11, 14, 47, 48) .
At the molecular level, a variety of genes modifying glucose metabolism, cell survival, vascular regulation, oxygen transport, and metabolic adaptive mechanisms is known to be activated in human fetoplacental tissues in response to hypoxia itself, ischemia, ischemia-reoxygenation, and oxidative stress (8, 11, 20) . The hypoxia-inducible transcription factors (HIF)-1 and HIF-2 are characterized as crucial regulators of a number of these adaptive processes to hypoxia/ischemia (13) . HIFs are heterodimers (HIF-␣/␤) consisting of the O 2 -regulated ␣-and the constitutively expressed ␤-subunit. The ␣-subunit is degraded rapidly by the ubiquitin-proteasome pathway mediated by specific prolyl residues that are hydroxylated by an enzyme family of HIF prolyl hydroxylases (prolyl hydroxylation domain protein) that require dioxygen and 2-oxoglutarate as cosubstrates (13) . Reduced activity of the prolyl hydroxylation domain proteins under hypoxia initiates stabilization of the HIF-␣ protein, heterodimerization (␣/␤) and activation of nuclear translocation, and binding to hypoxia response elements of promoters of specific responsive genes. HIF targets, such as erythropoietin, glycolytic enzymes, VEGF, and many others are involved in the modulation of oxygen and energy supply by activation of angiogenesis, erythropoiesis, glycolysis, and cell survival (13) . HIFs play a critical role in vascular and metabolic responses of fetoplacental tissues to hypoxia/ischemia as evident from human placental studies on preeclampsia (34) , intrauterine growth restriction (37, 49) , and gestations at high altitude (58) . From previous human in vivo studies (47, 48) on placentas derived from acute birth asphyxia, our group observed a significant upregulation of placental VEGF and adrenomedullin levels in relation to the degree of neonatal central nervous system complications. Thus, further work was focused on the question of whether analysis of placental genomic response to acute hypoxia might allow identifying early markers of perinatal hypoxic brain distress. Of note, human placenta is strongly involved in acute prenatal and late-gestational hypoxia (28, 45) , and, concerning clinical practicability, collection of placental specimens immediately after delivery is clinically and technically practicable without major preanalytic tissue degradation (47, 48) . By a mouse model of late-gestational systemic hypoxia [gestational day 20 (GD 20) , 6% O 2 , 6 h], we previously showed that HIFs and VEGF represent early markers of hypoxic distress in both placenta and brain of the fetal mouse (51) , although selected HIF target gene expressions revealed differential regulation suggesting time-and tissue-specific changes in response to acute hypoxia. In the brain, oxygen-sensitive gene responses have mostly been analyzed in models of hypoxic preconditioning (5, 18) when immature rodents were exposed to nonlethal hypoxia (8% O 2 , 3 h) and reoxygenation. Many of hypoxia-induced gene ex-pressions were found to be under the control of HIFs (5, 18, 53) . Of note, organ-and, of special interest in this context, age-specific sensitivity of HIF-regulated target genes to lowoxygen partial pressure is evident from different rodent models (5, 41) and is to be considered in the screening for early indicators of fetoplacental tissue hypoxia. Cell type-specific regulation seems also true for hypoxia-responsive genes other than HIF-dependent, such as transcription factors CELF (5) and Egr1 (52) , and other immediate early genes (IEG; c-Fos) (32) . Of note, studies on true intrauterine hypoxia are very limited (19, 51) .
The present study compares gene expression changes induced by acute systemic hypoxia between placenta and developing brain in a mouse model of late-gestational acute systemic hypoxia (GD 20, 6% O 2 , 6 h). The aim of the present study was to identify common endogenous hypoxia-induced mechanisms that play a role during the early period of oxygen deprivation without reoxygenation extending previous observations on selected HIF-dependent responses (51) . To this end, oligonucleotide microarray technology was used to investigate corresponding genomic response of the mouse placenta and developing brain to late-gestational acute hypoxia (6% O 2 , 6 h). We are convinced that the present data provide new insights in early molecular response to late-gestational hypoxic distress implicating novel diagnostic options for perinatal hypoxic brain injury.
METHODS
Animal experiments. Pregnant C57BL/6 wild-type mice (n ϭ 6) were exposed to systemic hypoxia (FI O 2 of 6% O2 for 6 h; Hypoxic Workstation INVIVO2 1000; Biotrace International, Bridgend, UK) at the last day of mouse gestation (GD 20) as previously described (50) . Controls (n ϭ 6) were incubated under room air. After the incubation period, brains of the pups and placentas were immediately dissected (without reoxygenation), frozen in liquid nitrogen, and stored at Ϫ80°C until mRNA extraction. Pregnant mice were provided with food and water ad libitum. Animal experiments were performed according to protocols approved by the Kantonales Veterinäramt, Zurich.
RNA isolation, microarray hybridization, and data analysis. For microarray analysis, placentas and the corresponding fetal brains of three hypoxic pups were used. Normoxic placentas and corresponding fetal brains of three pups that were not exposed to intrauterine hypoxia served as controls. All fetuses were derived from different pregnant mice (hypoxia, n ϭ 3; normoxia, n ϭ 3).
Total RNA was prepared from homogenized fetal brains and placental tissues using RNAzol-B isolation kit (WAK-Chemie Medical, Bad Homburg, Germany) according to the manufacturer's instructions. RNA was purified by RNeasy (Qiagen, Hilden, Germany). The quality of the isolated RNA was determined using a spectrophotometer (model no. ND-1000; NanoDrop Technologies, Wilmington, DE) and Bioanalyzer 2100 (Agilent, Waldbronn, Germany). All samples revealed a 260-to-280-nm ratio of 1.8:2.1 and a 28S-to-18S ratio of 1.5:2 and were thus of adequate quality for further processing. Total RNA samples (2 g) were used for double-stranded cDNA synthesis and in vitro transcription reaction to generate biotinylated cRNA using an IVT Labeling Kit (prod. no. 900449; Affymetrix, Santa Clara, CA). The cRNA was purified and quantified using BioRobot Gene Exp-cRNA Target Prep (Qiagen). The labeled cRNA quality was determined using the Bioanalyzer 2100.
Biotin-labeled cRNA samples (15 g) were fragmented randomly to 35-200 bp at 94°C in fragmentation buffer (prod. no. 900371; Affymetrix) and were mixed in 300 l of hybridization mix (prod. no. 900720; Affymetrix) containing a hybridization controls and control oligonucleotide B2 (prod. no. 900454; Affymetrix), before hybridization to GeneChip Mouse Genome 430 2.0 arrays for 16 h at 45°C. Arrays were washed in an Affymetrix Fluidics station 450 (protocol, FS450_0001). The Affymetrix arrays were scanned using an Affymetrix GeneChip Scanner 3000 to measure the fluorescent intensity emitted by the labeled target. The hybridizations were performed in triplicate on a separate microarray for normoxic and hypoxic placentas (n ϭ 6) and brains (n ϭ 6).
Microarray data analysis was performed using R/Bioconductor (16) . Raw hybridization intensities were summarized into probe set expression values using the Bioconductor package gcrma (55) . Probe sets with expression levels close to the background in all four conditions (hypoxic placenta, normoxic placenta, hypoxic brain, normoxic brain) were excluded from further analysis. Specifically, we chose the threshold expression value 20, which had to be satisfied in all three replicates of each condition. Hypoxia-regulated genes in both placenta and brain were determined using the limma package (40) of Bioconductor with a significance threshold of 0.01. Assessment of hypoxia-affected Gene Ontology categories was performed with ErmineJ (26) . Genes were selected as candidates for hypoxia-regulated genes if their expression was increased or decreased by at least a factor of two.
RNA isolation and RT-PCR. Total RNA was extracted using RNAzol-B isolation kit (WAK-Chemie Medical; Bad Homburg, Germany) according to the manufacturer's instructions. RT-PCR was performed as described previously (48) . One microgram of total RNA was used for each reverse transcription (Moloney murine leukemia virus reverse transcriptase; Invitrogen, Eugene, OR). RT-cDNA products were measured by quantitative TaqMan RT-PCR. Commercial reagents (TaqMan PCR Reagent Kit; Perkin-Elmer, Waltham, MA) and conditions were applied according to the manufacturer's protocol. The PCR reaction was performed in an ABI 7500 real-time PCR thermocycler (Applied Biosystems, Foster City, CA). All reactions were performed in duplicate using ␤-actin and porphobilinogen deaminase as endogenous controls.
The following primers and TaqMan probes based on published reports were used: ␤-actin, forward: 5=-ATGCTCCCCGGGCTGTAT-3=; reverse: 5=-TCACCCACATAGGAGTCCTTCTG -3=; TaqMan probe: 5=(FAM)-ATCACACCCTGGTGCCTAGGGCG-(TAMRA)-3=; Adm, forward: 5=-TGGACGAGCAGAACACAACTG-3=; reverse: 5=-CTGGCGG-TAGCGTTTGACA-3=; TaqMan probe: 5=(FAM)-CCCTACAAGCCAG-CAATCAGAGCGAA-(TAMRA)-3=; cFos, forward: 5=-CAGCCAAG-TGCCGGAATC-3=; reverse: 5=-CAACGCAGACTTCTCATCTTCAAG-3=; TaqMan probe: 5=(FAM)-AGCTGACAGATACACTCCAAGCG-GAGACA-(TAMRA)-3= Hk2, forward: 5=-CAACATCCTGATCGATT-TCACAA-3=; reverse: 5=-GCAGTCACTCTCGATCTGAGACA-3=; TaqMan probe: 5=(FAM)-CGCATCTCAGAGCGCCTCAAGACAA-(TAMRA)-3=; Jun, forward: 5=-CCAGCAATGGGCACATCAC-3=; reverse: 5=-TGCTCGTCGGTCACGTTCT-3=; TaqMan probe: 5=(FAM)-TACACCGACCCCCACCCAGTTCTTG-(TAMRA)-3=; Pbgd, forward: 5=-ACAAGATTCTTGATACTGCACTCTCTAAG-3=; reverse: 5=-CCTTCAGGGAGTGAACAACCA-3=; TaqMan probe: 5=(FAM)-TCTAGCTCCTTGGTAAACAGGCTCTTCTCTCCA-(TAMRA)-3=; Phd3, forward: 5=-AGCCCATTTTTGACAGACTTCTG-3=; reverse: 5=-AGCGTACCTGGTGGCATAGG-3=; TaqMan probe: 5=(FAM)-TC-TGGTCAGACCGCAGGAATCCACAT-(TAMRA)-3=; Vegf, forward: 5=-GCACTGGACCCTGGCTTTACT-3=; reverse: 5=-ACTTGATCACT-TCATGGGACTTCTG-3=; TaqMan probe: 5=(FAM)-CCATGCCCAGTG-GTCCCAGGCTG-(TAMRA)-3=.
Real-time PCR analysis for Bnip3 has been performed using mouse-specific TaqMan-based gene expression assay (cat. no. Mm00833810_g1; Applied Biosystems).
The thermocycler parameters were 50°C for 2 min (for carryover prevention with Uracil-N-glycosylase), 95°C for 10 min (for hot-start PCR), followed by 40 cycles of 95°C for 15 s and 60°C for 1 min.
Immunohistochemistry. For immunohistochemical analysis 3-m thick sections of paraformaldehyde-embedded tissues were used (3 brains and corresponding placentas per group). After heat-induced epitope retrieval and being washed (TBS/Tween 20 0.05%) and blocked with normal goat serum, sections were incubated with the polyclonal rabbit anti-c-Fos (1:200; GeneTex, Irvine, CA) overnight at 4°C. Negative controls were performed by omitting the primary antibody. After being washed, sections were incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen) secondary antibody for 60 min. To define the identity of cerebral Fos-immunopositive cells, brain sections were costained with antibodies against NeuN (neuronal nuclei), a routinely used neuronal marker, or glial fibrillary acidic protein (Sigma, St. Louis, MO) routinely used to identify glial cells, especially astrocytes. Incubations of monoclonal mouse anti-NeuN (Chemicon, Hampshire, UK) and polyclonal mouse anti-glial fibrillary acidic protein were performed at room temperature for 2 h, followed by Alexa Fluor 594-conjugated goat anti-mouse secondary antibody (Invitrogen). Cell nuclei were labeled with 4,6-diamidino-2-phenylindole. During all incubations, sections were stored in a humidified chamber.
Statistical analysis. Microarray data analysis is described above. Real-time PCR data are expressed as means Ϯ SE. Statistical significance was determined by one-way ANOVA and two-way ANOVA for repeated measurements (P Ͻ 0.05).
RESULTS
Using high-density oligonucleotide microarray technology, we initially analyzed the primary mouse placenta and brain transcriptomes for hypoxia-induced alterations in gene expression compared with normoxic controls. Under normoxic conditions, we analyzed 18,980 probes mapping to 11,110 known different genes in the placenta and 21,623 probes mapping to 11,995 known different genes in the fetal brain. Under hypoxic conditions (6% O 2 , 6 h), we investigated 18,956 probe sets mapping to 11,053 different known genes in the placenta and 21,435 probe sets mapping to 11,874 known different genes in the fetal brains. The overall gene expression was similar under normoxic and hypoxic conditions in both tissues; however, there was a trend to higher overall transcriptional activity in brains compared with placentas.
Hypoxia-induced alterations of gene expression in mouse placenta and developing brain and related gene ontology categories. Using the limma package, we determined transcripts that exhibited the most significant changes in expression level in response to hypoxia compared with normoxia, while having the same consistent behavior in both organs. With the significance threshold of P ϭ 0.01 we found 2,536 probe sets mapping to 2,019 genes representing 12.4% of probe sets that were interrogated (20,511 probe sets that had signals sufficiently above background). Interestingly, about one third of these probes was found to be upregulated (852 probe sets; 33.5%), while two thirds were downregulated (1,684 probe sets; 66.4%). The false discovery rate for the list of hypoxiaregulated genes was 6.4%.
To characterize effects of systemic hypoxia on gene expression in both fetal tissues we used the ErmineJ (26) application to categorize hypoxia-induced gene responses. When mapping the differentially expressed genes to gene ontology categories we found a highly significant overlap with a set of biological process categories (listed in Table 1 ). These included genes involved in RNA processing, mRNA metabolic process, mRNA processing, snRNA metabolic process, RNA splicing, glycolysis, glucose catabolic process, and ubiquitin cycle. While genes involved in glycolysis, glucose catabolic processes, energy derivation by oxidation of organic compounds, and ubiquitin cycle were upregulated, those genes encoding functions involved in RNA processing, mRNA metabolic process, mRNA processing, and snRNA metabolic processes were downregulated.
Among molecular function categories (Table 2) we found transcription factor activity and RNA binding mainly affected and primarily upregulated. With respect to the group of upregulated genes, we also identified a highly significant overlap with genes encoding various oxidoreductase activities, ubiquitin-protein ligase and dioxygenase activity, and L-ascorbic acid binding.
Candidate marker genes for hypoxia. When looking for candidate marker genes for hypoxia we further restricted the set of regulated genes to those that changed their expression upon hypoxia at least twofold up or down. This reduced the list to 91 probes mapping to 77 genes, that show an upregulation and 95 probes mapping to 86 genes with downregulation. We now had an approximately equal number of up-and downregulated genes, suggesting that the observed overrepresentation of downregulated genes, when only looking at significance but not at fold changes, may be due to a general slowdown of cellular activities due to acute hypoxia.
From our mapping of the list of responsive marker genes for hypoxia to known diseases using the MetaCore software, we found that our candidate list had the highest overlap with the list of genes known to be involved in anoxia (significance of overlap: P ϭ 7.1 * 10 Ϫ10 ). The MetaCore database includes the list of genes that are reported in the literature as being involved in 633 specific diseases. This result serves as a positive control and shows that the candidate list indeed contains a large proportion of known hypoxia-responsive genes but also other genes that are not yet described as being hypoxia related (Table 3-5) .
Hypoxia-induced transcripts in placenta and developing brain identified by microarray analysis. In both placentas and corresponding brains, systemic hypoxia significantly induced several genes regulating transcriptional activity (Table 3) . Our microarray profiling showed that genes were included, encoding high-mobility group box transcription factor 1 (Hbp1), Arg/Ser-rich splicing factor Sfrs7, Polypyrimidine tract binding protein 2 (Ptbp2), early growth response 1 (Egr1), Fos, Jun, Bhlhb2, and RNA polymerase II polypeptide A (Polr2a). In the brain, upregulation of several additional regulators of transcriptional activity have been identified including EGL nine homolog 3 (Egln3; also known as Phd3) and genes involved in ubiquitin cycle (Ube2r2, Usp7); however, their induction was not paralleled in the placenta at the above-defined level of significance (data not shown).
Another class of genes induced by hypoxia in both placenta and brain consisted of genes that are involved in vascular development, cell growth, and cellular differentiation (Table  3) . This was evident from upregulation of guanine nucleotide binding protein Gna13, adrenomedullin (Adm), vascular endothelial growth factor A (Vegf), growth factor receptor bound protein 2-associated protein 2 (Gab2), cysteine-rich protein 61 (Cyr61), and suppressor of cytokine signaling 2 (Socs2). Fold changes of mRNA expressions were higher in developing brain than in placenta except Gna13 and Cyr61. Organ-specific changes were also evident, e.g., from Flt-1 receptor and Edn1 mRNA expressions, which were significantly upregulated in developing brain but not in the placenta (data not shown).
A further category of genes upregulated by hypoxia in both tissues consisted of genes encoding functions involved in carbohydrate metabolism. Known HIF target genes pyruvate dehydrogenase kinase (Pdk1) and hexokinase 2 (Hk2) were upregulated in placenta and brain. Among genes of this category 6-phosphofructo-2-kinase (Pfkfb3) and Pdhx transcripts were significantly induced in the brain but not in the placenta (data not shown).
Furthermore, genes encoding functions involved in cell proliferation and apoptosis were induced in both tissues (Table  3) . They consisted of proapoptotic factors, such as Bnip3, Bnip2, dual specificity phosphatase 1 (Dusp1), and immediate early response 3 (Ier3). Expression of Dusp1 was higher in the placenta than in developing brain and, therefore, was not assessed as placental marker of fetal hypoxia.
Hypoxia-repressed transcripts in placenta and developing brain identified by microarray analysis. Hypoxia-repressed genes, which showed temporally parallel downregulation in placenta and developing brain during late-gestational systemic hypoxia are summarized in Table 4 . Specifically, the group of common downregulated genes mainly included genes involved in RNA binding and translation (Rbm3, Thap2, Lig4, Rbm12b) as well as regulation of transcriptional activity (Cebpg, Nfya, E2f6). Interestingly, in the brain hypoxia-repressed transcripts encoding regulation of neurotransmitter receptors (Gabra2, Narg1l, Npy1r) and voltage-gated sodium channel type II␤ (Scn2b) were found to be involved in early response to systemic hypoxia (data not shown).
Finally, several genes that were not known to be induced by hypoxia have been identified as hypoxia responsive by our microarray analysis. A summary of selected genes is listed in Table 5 , demonstrating those that were identified for the first time as being hypoxia responsive in mouse placenta and developing brain.
Hypoxia-induced genes in placenta and brain confirmed by RT-PCR. Since our microarray profiling revealed genes encoding transcription regulatory factors and HIF-regulated genes markedly induced by hypoxia, in the next step we confirmed the results from microarray analysis by quantitative RT-PCR analysis of selected hypoxia-responsive genes in both placenta and brain. Figures 1 and 2 demonstrate our data of PCR analysis with RNA prepared from three independent pairs of placenta and corresponding brain per group. This confirmed hypoxia-induced changes of mRNA expression belonging to HIF-regulated genes and IEG. Specifically, the group of consistently upregulated transcripts in both tissues included the HIF-regulated genes Adm, Vegf, Bnip3, Ier3, and Dusp1 (Fig. 1) . HIF-regulated genes upregulated in developing brain but not in the corresponding placenta were prolyl hydroxylase domain 3 (Phd3; Egln3) and hexokinase 2 (HK2) (Fig. 1) .
Among the group of hypoxia-induced HIF-independent genes we analyzed mRNA expression of Fos and Jun that act as inducible regulators of transcription and belong to IEG. Both factors were upregulated in placentas and corresponding brains (Fig. 2) confirming present microarray data. Hypoxia- *Acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; †acting on single donors with incorporation of molecular oxygen, incorporation of 2 atoms of oxygen; ‡acting on single donors with incorporation of molecular oxygen; §acting on paired donors, with incorporation or reduction of molecular oxygen.
induced induction of c-Fos was confirmed by immunohistochemical analysis demonstrating cellular accumulation of cFos in placental villi of the labyrinthine layer (Fig. 3, A and B) and in neurons of the cerebral cortex (Fig. 3, C and D) during acute systemic hypoxia.
DISCUSSION
The present comparison of hypoxia-induced alterations of gene expression in mouse placenta and developing brain showed that both tissues share common hypoxia-responsive genes during acute systemic hypoxia. The most important observation was that both tissues are highly responsive to hypoxia at the level of gene expression involving different rapid response systems. These include transcription factors HIFs and IEG, and apoptosis-promoting factors that were upregulated, as well as genes modulating RNA binding and translation that mainly were downregulated. Our data suggest that severe late-gestational intrauterine hypoxia leads to fetal hypoxia. Importantly, the specified hypoxia-induced genomic response of the mouse placenta mirrors that of developing brain in a temporally parallel manner. This fact implicates future diagnostic and therapeutic options. Specifically, during the early period of systemic hypoxia we identified hypoxia-induced genes encoding several transcription factors and regulators of transcriptional activity. In part, the results fit nicely with previous studies on hypoxia-induced gene expression changes in neonatal rodent brain (5, 53) , a fact that strongly supports the validity of our microarray analysis. Functional activity of the HIF system in our experimental setting is obvious from upregulation of various known HIFregulated target genes such as Adm, Vegf, Bnip3, Ier3, and Dusp-1 (7, 13), indicating its immediate availability among early response to systemic hypoxia. Functionally, these genes encode mechanisms essential in endogenous adaptation to hypoxia, such as vascular regulation, cell survival, and proliferation (Adm, Vegf, Ier3) (13), as well as glycolysis and mitochondrial oxygen consumption (Pdk1, Hk2) (33) . Interestingly, specific vasoactive HIF-dependent genes (Adm, Vegf) revealed temporally parallel induction in both placenta and brain. In agreement to our previous observations on placental and cerebral HIF-␣ and VEGF upregulation during late-gestational systemic hypoxia in mice (51), the present data confirm similar cellular sensitivity of these selected vasoactive factors to hypoxia stress in both tissues. This supports the hypothesis that placental HIF-regulated factors reflect attractive candidates of cerebral hypoxia markers in the experimental setting of late-gestational systemic hypoxia. Indeed, by analyzing a small group of asphyxiated newborns, our group has identified placental VEGF and adrenomedullin induction as early indicators of developing hypoxic-ischemic encephalopathy (47, 48) . This is in contrast to placental HIF-regulated somatotrophic and growth factors, such as leptin and IGF-I and II that were not related to the degree of cerebral complications (49) . Of note, concerning organ-specific HIF target gene regulation, a comparison of hypoxia-responsive gene expressions in multiple organs of 7-day-old rats exposed to hypoxic preconditioning (8% O 2 , 3 h) revealed selective Adm and Vegf mRNA upregulation in developing brain but not in heart, kidney, liver, and lung (5) .
Proapoptotic effects of HIFs depending on the degree of hypoxia have been discussed (21) . Supporting severity of hypoxia in our model proapoptotic HIF-dependent factors (Bnip3, Ier3, Dusp-1) were activated in both placenta and brain. Of note, degree of hypoxia used in our model that is comparable to the degree of hypoxia in altitudes of 9,000 -10,000 m above sea level (22) was more severe than that used in preconditioning experiments (4, 5) . Our results identify Bnip3, a proapoptotic member of the Bcl-2 family, as a hypoxia-responsive gene in developing mouse brain at GD 20 in agreement with studies on adult rat brain ischemia in vivo (1) and immature rat cortical neurons in vitro (39) . In contrast to our results, in these former studies hypoxia was shown to was recently shown in vitro in hepatic cell lines (7), although this stress-inducible protein involved in apoptosis as well as cell proliferation is known to be under the control of several transcription factors including c-myc, p53, Sp1, and NF-B (55). So far, cerebral induction of Ier3 during the early period of systemic hypoxia (1-6 h of preconditioning) has been shown exclusively in adult mice (44) but not in neonatal rodents (5) . Comparable data on placental Ier3 expression are not available. Dusp1 that negatively regulates a number of cellular processes controlled by MAPK, and as recently characterized by hepatic cell culture experiments (7), is characterized as a hypoxia-responsive gene transcriptionally regulated by HIF-1␣ and HIF-2␣. In agreement with Bernaudin et al. (5), we found Dusp1 among the group of genes early upregulated in hypoxic developing brain, which might result in increased cellular susceptibility to oxidative damage (27) . Of note, cells other than neurons and astrocytes were assumed to be responsible for hypoxia-induced upregulation in immature rat brain (4). Our data demonstrate that Bnip3, Ier3, and Dusp1 belong to the group of hypoxia-responsive genes controlled by HIFs involved in early steps of hypoxia-induced apoptosis in developing mouse brain and placenta. Moreover, in response to late-gestational acute hypoxia we identified increased gene expressions encoding HIF-independent regulators of transcriptional activity. Focusing on early hypoxia-induced responses, we found temporally parallel increases of Fos and Jun, encoding homo-and heterodimeric transcription factor AP-1 complexes, as well as Egr1 und Bhlhl2 in both placenta and brain at an early stage of development (GD 20) . This is strongly supported by our RT-PCR data and immunohistochemical results. Beside cytokines and growth factors (23) , hypoxia/ischemia is a known stimulus of IEG transcriptional activation. Recent data on increased expression of c-Fos in ischemia-resistant hippocampal neurons of 7-day-old mice (32) demonstrated a transient increase of c-Fos mRNA and protein expression but not c-Jun within 3 to 6 h in selective brain regions. In agreement with our data, other studies (17, 31) have identified immediate but transient upregulation of both c-Fos and c-Jun mRNA levels within 1-3 h postischemia with temporal and regional colocalization in response to ischemia in P7 rat brains that were analyzed after recovery periods ranging from 10 min to 24 h. Differential regulation of both c-Fos and c-Jun in the immature rodent brain in relation to spatial and temporal distribution (32) and different experimental settings, including experimental ischemia, could explain differing observations. Functionally, a dual role of c-Jun and c-Fos in neonatal hypoxia is assumed as emerging evidence suggests that they mediate neurodegeneration as well as cell survival, brain plasticity, and repair (35, 59) . Protective effects are obvious from studies on the essential role of c-Fos and c-Jun in cell differentiation, proliferation, and repair mechanisms of the developing rodent brain (32) and placenta (3, 23, 36) .
Present data on hypoxia-induced upregulation of the plasticityrelated gene Egr1 in the developing brain is in agreement with Gubits et al. (17) ; however, studies on the regulation and function of Egr1 in fetal tissues are limited. Hypoxia-induced Egr1 upregulation within 2-24 h upon transient focal brain ischemia in adult rats (52) was found to contribute to postischemic inflamma- Fig. 2 . Hypoxia-induced mRNA expression of Jun (A) and Fos (B) in developing mouse brain (n ϭ 3) and corresponding placenta (n ϭ 3) at GD 20 upon intrauterine systemic acute hypoxia (6% oxygen, 6 h) compared with normoxic controls (n ϭ 3/tissue). tion. In neonatal rats (P2-P7), iron-deficiency anemia decreased hippocampal Egr1 expression that was associated with lowered brain-derived neurotrophic factor (Bdnf) and doublecortin expression (46) supporting involvement of Egr1 in neuronal differentiation of developing hippocampus.
Bhlhb2 characterized as a member of the basic helix-loophelix (bHLH) superfamily of transcription factors is expressed in neurons of rat cerebral cortex and hippocampus (38) and is regulated by neurotrophins and glutamate receptors (38) . Recently, Bhlhb2 (also known as Sharp-2 and DEC-1) was characterized as suppressor of (exon 4-specific) Bdnf gene transcription in vitro, and therefore, its involvement in the modification of neuronal excitability and synaptic plasticity is assumed (24) . Here, we showed hypoxia-induced upregulation of Bhlhb2 mRNA in developing brain in vivo. Interestingly, Bhlhb2 mRNA levels were increased in hypoxic mouse placenta, in parallel. Thus, our data support IEG characteristics of Bhlhb2.
Among HIF-independent growth and vasoactive factors we identified angiogenesis-related, immediate early gene Cyr61 (cystein-rich 61, also known as CCN1), adapter protein Gab2, and Socs2 to be involved in early hypoxia response of both placenta and brain at GD 20. The proangiogenic factor Cyr61 was recently shown to be enhanced upon hypoxia in chorioretinal endothelial cells (57) and in hypoxic regions of tumors in vivo modulating growth and invasiveness (29) . Here, we report for the first time that Cyr61 represents an IEG involved in hypoxic response of the developing mouse brain and placenta in vivo under conditions of acute hypoxia. During normal human and mouse placental development Cyr61 modifies placental angiogenesis (15, 30) . In contrast to our data on acute hypoxia, expression of Cyr61 was decreased in human placenta of women with early-onset preeclampsia (15) , which is suggested as one explanation of disturbed angiogenesis and trophoblast migration underlying preeclampsia (28) . Furthermore, our data propose Gab2 as a hypoxia-responsive transcript that exerts temporally parallel induction in mouse placenta and developing brain. Gab2 acts as an adapter protein to promote mitogenic stimulation of ERK kinase activity and to control intracellular signaling cascades (42, 60) . Evidence is present that it promotes cell growth and transformation in various human organs including brain and placenta (60) and is considered as positive mediator of cytokine and growth factor signaling (42) .
Finally, the present microarray analysis identified hypoxiarepressed transcripts in placenta and brain that are involved in RNA binding and translation (Rbm3, Thap2, Rbm12b) as well as regulation of transcriptional activity (Cebpg, Nfya, E2f6). Some of them have not been described as hypoxia-responsive genes in fetal tissues in vivo. E2F6, known as a potent transcriptional repressor involved in cell cycle regulation and modification of cellular proliferation (25) , recently has been shown to modify CoCl 2 -induced apoptosis via modulation of the E2F1/Apaf-1 pathway in vitro in HEK 293 cells (56) . In contrast, our in vivo results demonstrate downregulation of E2f6 in response to acute hypoxia in both placenta and brain. This might increase cellular sensitivity to hypoxiainduced apoptosis by upregulating E2F1-dependent proapoptotic genes (56) .
Perspectives and Significance
Present results indicate that the placenta and developing brain are highly responsive to acute systemic hypoxia at the level of gene expression involving different rapid response systems in parallel. Among transcription factors, HIF, AP-1 (Fos, Jun), and Egr1 seem to reflect marker genes of tissue hypoxia in both placenta and brain showing similar temporal kinetics and organ sensitivity to acute systemic hypoxia. Thus, our data provide basic information for further investigations on pathophysiology of early fetal hypoxic response in view of novel diagnostic concepts.
